Genetic heterogeneity profiling for HER2 positive single circulating tumor cell (CTC) in metastatic breast cancer (MBC) by application of DEPArray™ System and single cell DNA sequencing for HER2 positive single circulating tumor cell (CTC) in metastatic breast cancer (MBC) by application DEPArray™ system and single cell DNA sequencing

被引：0

作者：

Zhang, Qiang ^{[1
]}

Gerratana, Lorenzo ^{[2
]}

Pivarski, Kara L. ^{[1
]}

Wang, Xinkun ^{[1
]}

Ji, Zhe ^{[1
]}

Stroup, Emily ^{[1
]}

Vagia, Elena Vagia ^{[1
]}

Davis, Andrew Adam Davis A. Adam ^{[1
]}

Shah, Ami ^{[1
]}

Kerby, Katy L. ^{[1
]}

Flaum, Lisa Flaum ^{[1
]}

Wehbe, Firas ^{[1
]}

Zhang, Youbin ^{[1
]}

Qiang, Wenan ^{[1
]}

Behdad, Amir ^{[1
]}

Gradishar, William ^{[1
]}

Platanias, Leonidas ^{[1
]}

Cristofanilli, Massimo ^{[1
]}

机构：

[1] Northwestern Univ Evanston, Chicago, IL USA

[2] Univ Udine, Udine, Italy

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-3120

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

3120

引用

页数：2

共 50 条

[31] Diagnosing Intratumor Heterogeneity in Metastatic Colorectal Cancer with Single Cell DNA Sequencing
Leung, M. L.
Wang, Y.
Kim, C.
Gao, R.
Sei, E.
Maru, D.
Kopetz, S.
Navin, N.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2015, 17 (06): : 818 - 819
[32] CLINICAL UTILITY OF CIRCULATING TUMOR CELL (CTC) ENUMERATION-BASED LIQUID BIOPSY AND HER2 CTC ASSESSMENT IN PATIENTS WITH METASTATIC BREAST CANCER: OVERVIEW OF CURRENT AVAILABLE DATA AND INTERVENTIONAL TRIALS
Cristofanilli, M.
de Snoo, F.
Stork-Sloots, L.
Hansen, T.
Garay, C. A.
Lazaro, S.
Chabut, D.
Picardo, F.
Warren-Mora, N.
Kuhr, F.
Spinner, D.
VALUE IN HEALTH, 2023, 26 (12) : S433 - S433
[33] Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer
Kyoungmin Lee
Jongwon Lee
Jungmin Choi
Sung Hoon Sim
Jeong Eun Kim
Min Hwan Kim
Yeon Hee Park
Jee Hyun Kim
Su-Jin Koh
Kyong Hwa Park
Myoung Joo Kang
Mi Sun Ahn
Kyoung Eun Lee
Hee-Jun Kim
Hee Kyung Ahn
Han Jo Kim
Keon Uk Park
In Hae Park
Scientific Reports, 13
[34] HER2, AR protein expression and chromosomal instability in circulating tumor cells (CTCs) of metastatic breast cancer (MBC) patients (pts)
Ontiveros, Priscilla
Landaverde, Connie
Levin, Maren K.
Hippely, Sarah
Landers, Mark
Wang, Yipeng
Dittamore, Ryan
O'Shaughnessy, Joyce A.
CANCER RESEARCH, 2019, 79 (13)
[35] Circulating tumor cells (CTCs) detect HER2+status and phenotypic heterogeneity in metastatic breast cancer (MBC)
Austin, Laura
Mu, Zhaomei
Avery, Tiffany
Jaslow, Rebecca
Paolillo, Carmela
Toss, Angela
Fortuna, Paolo
Zhong, Ye
Yang, Hushan
Cristofanilli, Massimo
CANCER RESEARCH, 2015, 75
[36] Intra-tumoral differential expression analysis in HER2 positive breast cancer using single-cell RNA sequencing analysis
Shiino, Sho
Nakayama, Jun
Tokura, Momoko
Yamamoto, Yusuke
Yoshida, Masayuki
CANCER SCIENCE, 2023, 114 : 1582 - 1582
[37] FLUCTUATION OF HER2/NEU PROTEIN LEVELS IN CIRCULATING TUMOR CELLS (CTCS) FROM METASTATIC BREAST CANCER (MBC) PATIENTS (PTS)
Bessi, S.
Galardi, F.
Truglia, M. C.
Pestrin, M.
Chiarelli, C.
Cappadona, S.
Licitra, S.
Biganzoli, L.
Giannini, A.
ANNALS OF ONCOLOGY, 2009, 20 : 50 - 50
[38] DURABLE REMISSIONS WITH TRASTUZUMAB TREATMENT FOR HER2 POSITIVE METASTATIC BREAST CANCER - SINGLE CENTER EXPERIENCE
Tomasevic, Zoran
Tomasevic, Zorica
Neric, Dobrica
Milosevic, Snezana
Ivana, Bozovic-Spasojevic
Zdravko, Zdrale
Sarcevic, Aleksandra
Kolarevic, Daniela
BREAST, 2015, 24 : S42 - S42
[39] Single institute experience of treatment for metastatic HER2 positive breast cancer patients with trastuzumab deruxtecan
Kojima, Yasuyuki
Tsugawa, Koichiro
ANNALS OF ONCOLOGY, 2021, 32 : S338 - S338
[40] Enabling HER2 and androgen receptor (AR) protein expression and localization in circulating tumor cells (CTCs) of ER(+/-)HER2(-) metastatic breast cancer (MBC) patients (pts)
Ontiveros, P.
Landaverde, C.
Graf, R.
Levin, M. K.
Hippely, S.
Wang, Y.
Landers, M.
Dittamore, R.
O'Shaughnessy, J. A.
CANCER RESEARCH, 2019, 79 (04)

← 1 2 3 4 5 →